Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome
Authors:
- Beate NieslerBNBeate Niesler
- Bernd FrankBFBernd Frank
- Johannes HebebrandJHJohannes Hebebrand
- Gudrun RappoldGRGudrun Rappold
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 15 (4) , 303-304
Abstract
Serotonin has been implicated in a variety of neuropsychiatric disorders. Serotonergic dysfunction is thought to be involved in the pathophysiology of the Gilles de la Tourette Syndrome (GTS). GTS is characterized by multiple vocal and motoric tics. Among selective, competitive 5-HT3 receptor antagonists, ondansetron represents a promising drug in GTS treatment. In our study both serotonin receptor subunit genes, HTR3A and HTR3B, were examined for sequence variations in GTS patients. We have analyzed DNA samples from 49 patients by SSCP and dHPLC. In HTR3A, we detected five mutations and in HTR3B the analysis revealed six sequence variants. Statistical analysis rated all variants as probably non-disease-related polymorphisms. Yet a certain effect of the detected variants on the severity of the disease cannot be excluded.Keywords
This publication has 4 references indexed in Scilit:
- Investigation of the human serotonin receptor geneHTR3Bin bipolar affective and schizophrenic patientsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2004
- Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients.2001
- Ondansetron treatment in patients with Tourette??s syndromeInternational Clinical Psychopharmacology, 1999
- Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndromeJournal of Psychiatric Research, 1997